[Psoriasis and atherothrombotic disease].
Psoriasis and atherosclerosis share immunoinflammatory mechanisms and patients with psoriasis may carry an excess of cardiovascular risk factors (hypercholesterolemia, hypertension, obesity, metabolic syndrome, diabetes mellitus, smoking etc.) and increased risk of atherothrombotic disease. The current review summarises the available evidence in this area of research and calls for increased awareness of cardiovascular risk assessment and treatment in patients with psoriasis.
Ahlehoff
Ole
O
Kardiologisk Afdeling P, Gentofte Hospital, 2900 Hellerup, Denmark.
Gislason
Gunnar H
GH
Skov
Lone
L
Hansen
Peter Riis
PR
D050197:Atherosclerosis / Q000209:etiology* / Q000276:immunology; D015415:Biomarkers / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000209:etiology / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006801:Humans; D011565:Psoriasis / Q000150:complications* / Q000276:immunology / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology* / Q000276:immunology
D015415:Biomarkers